Thermo Fisher Scientific announced today that it introduced more sustainable packaging for 125,000 Invitrogen antibodies. The Waltham, Massachusetts-based company said the transition from cold-chain packaging to ambient temperature shipping from distribution center to customer reduces package material mass and improves the customer experience. This comes as part of the company’s global sustainability efforts. According to…

Thermo Fisher Scientific has expanded its clinical research laboratory building at its good manufacturing practices (GMP) lab in Middleton, Wisconsin. The new $58 million investment adds 72,500 sq ft. to the company’s footprint and increases the site’s chemistry, manufacturing, and control analytical capabilities for biopharmaceutical therapy development. “As research in biopharmaceutical therapies continues to rapidly…

Thermo Fisher Scientific announced that it opened a new clinical and commercial ultra-cold facility in the Netherlands. The company aims to expand its clinical trial network in Europe and accelerate the development of advanced therapies. Its new current good manufacturing practice (cGMP) facility in Bleiswijk offers pharmaceutical and biopharma customers tailored, end-to-end support throughout the…

Thermo Fisher Scientific posted third-quarter results today that beat the consensus forecast on Wall Street. The company reported profits of $1.5 billion, or $3.79 per share, on sales of $10.7 billion for the three months ended Sept. 30, for a bottom-line loss of 21.3% on sales growth of 14.4% compared with Q3 2021. Adjusted to…

Thermo Fisher Scientific (NYSE:TMO) announced today that it unveiled the Gibco CTS DynaCellect magnetic separation system. Waltham, Massachusetts-based Thermo Fisher designed DynaCellect to help cell therapy developers easily move from process and clinical development to commercial manufacturing. The next-generation instrument features cell isolation, activation and depletion along with Dynabeads magnetic beads removal. Thermo Fisher said…

COVID-19 vaccine development and rollout were crucial to gaining control of the pandemic. When the success of these efforts became dependent on the ability to maintain lower than typical temperatures during distribution, the importance of reliable and continuous cold chain solutions for mRNA-based formulations was thrust into the spotlight. Beyond pandemic mitigation measures and outside…

Thermo Fisher Scientific (NYSE:TMO) will spend more than $600 million to expand its bioprocessing production capabilities through 2022, the Waltham, Mass.–based company said today. Investments will more than double Thermo Fisher’s manufacturing capacity so that it can better support biopharma customers ramping up to meet not only short-term demands related to COVID-19 but also long-term…

Chemical company Avantor (NYSE:AVTR) recently said it expects to achieve sales growth of 5.4% in its third fiscal quarter of 2020, with biopharma and healthcare businesses driving quarterly revenues of $1.6 billion. Avantor offers a range of ultra-high-purity materials to biopharma companies. This year, the company also created a COVID-19 division to support virus detection, therapy…

Thermo Fisher Scientific (NYSE:TMO), the maker of scientific instruments, reagents and consumables, is having a banner year. The Waltham, Mass.-based company’s stock has hit an all-time high of $481.99. That amounts to a 48% increase since the beginning of the year. Thermo Fisher raked in $2 billion in COVID-19 revenue from July to September, driving a…